SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-044285
Filing Date
2023-08-02
Accepted
2023-08-02 18:02:17
Documents
1
Period of Report
2023-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3152
  Complete submission text file 0001209191-23-044285.txt   4631
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Issuer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PRYOR CASHMAN LLP 7 TIMES SQUARE NEW YORK NY 10036
Business Address
Williams Donald Allen (Reporting) CIK: 0001620013 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38052 | Film No.: 231137334